We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0499 | -1.17411764706 | 4.25 | 4.31 | 3.9216 | 6236 | 4.11817071 | CS |
4 | 0.3901 | 10.2388451444 | 3.81 | 4.6445 | 3.81 | 23173 | 4.25294492 | CS |
12 | 0.4601 | 12.3021390374 | 3.74 | 5.0899 | 3.5601 | 25229 | 4.07939202 | CS |
26 | 0.2001 | 5.0025 | 4 | 5.2 | 2.78 | 18645 | 3.97294827 | CS |
52 | 0.7001 | 20.0028571429 | 3.5 | 5.2 | 2.78 | 11965 | 3.96983505 | CS |
156 | -9.0999 | -68.4203007519 | 13.3 | 14.8 | 2.40101 | 50189 | 7.71854791 | CS |
260 | -11.7999 | -73.749375 | 16 | 58.5 | 2.40101 | 833427 | 27.88337783 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions